PFE: Pfizer Inc. 2020-06-30 19:30:00 FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
HALO: Halozyme Therapeutics, Inc. 2020-06-29 12:54:00 Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
EKSO: Ekso Bionics Holdings, Inc. 2020-06-25 08:30:10 Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
MDT: Medtronic plc 2020-06-25 08:00:10 FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology
RYTM: Rhythm Pharmaceuticals, Inc. 2020-06-24 08:00:10 Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers
MYOV: Myovant Sciences, Inc. 2020-06-23 07:30:10 Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
KPTI: Karyopharm Therapeutics Inc. 2020-06-22 11:25:10 Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
EVOK: Evoke Pharma, Inc. 2020-06-19 15:32:10 FDA Approves Evoke’s GIMOTI™
REGN: Regeneron Pharmaceuticals, Inc. 2020-06-19 13:44:00 FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-Administration
LLY: Eli Lilly and Company 2020-06-15 22:21:00 FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
MNTA: Momenta Pharmaceuticals, Inc. 2020-06-15 07:05:10 Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M281) in Generalized Myasthenia Gravis (gMG)
ARDX: Ardelyx 2020-06-15 08:00:00 Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
ABBV: AbbVie 2020-06-15 08:15:00 FDA Approves JUVÉDERM® VOLUMA(TM) XC for Enhancement of the Chin Region
AMPH: Amphastar Pharmaceuticals, Inc. 2020-06-09 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
AGIO: Agios Pharmaceuticals, Inc. 2020-06-08 16:01:10 Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
ZLAB: Zai Lab Limited 2020-05-28 07:37:40 Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer
CERC: Cerecor Inc. 2020-05-28 07:00:10 Cerecor Announces FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS
RARE: Ultragenyx Pharmaceutical Inc. 2020-05-15 08:00:10 Ultragenyx Announces Positive Data from Confirmatory Cohort of Phase 1/2 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)